Conte Pier Franco,...,Stamatovic Ljiljana,...,(broj koautora 21) (2020) Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer, CANCER, vol. 126, br. 13, str. 3132-3139 (Article)